Gsk Bribery
- All
- News
-
Drugmaker GSK Investigating Corruption Allegations in UAE
Britain's biggest pharmaceuticals group confirmed the investigation following allegations of improper payments set out in a whistleblower's email sent to its top management on Monday. The email, purporting to be from a GSK sales manager in the Gulf state, was seen by Reuters.
-
China to Try Foreign Investigators Linked to GSK
British national Peter Humphrey and his wife Yu Yingzeng, an American citizen, will on August 7 face charges of illegally obtaining personal information, a family friend who asked not to be identified told AFP.
-
Sex Video is New Twist in GSK China Bribery Scandal
GSK, which described the bribery allegations as "shameful" when they came to light last year, said on Sunday that it was continuing to cooperate fully with Chinese authorities on the ongoing investigation.
-
UK Fraud Office Probes GSK After Claims of Foreign Bribery
The Serious Fraud Office (SFO) said on Tuesday that its director had "opened a criminal investigation into the commercial practices of GlaxoSmithKline and its subsidiaries", confirming an earlier brief statement from the company.
-
Chinese Police Charge Former GSK China Head With Bribery
Mark Reilly, former head of China operations, and two other executives, Zhang Guowei and Zhao Hongyan, were also suspected of bribing officials in the industry and commerce departments of Beijing and Shanghai, Xinhua said.
-
GSK faces bribery investigation in Poland: report
The BBC reported that 11 doctors and a GSK regional manager have been charged over alleged corruption between 2010 and 2012.
-
GlaxoSmithKline sacks some China staff for malpractice: report
GlaxoSmithKline, facing allegations of bribery in China, has dismissed some employees in the country over failure to comply with expenses rules, a person familiar with the situation said on Friday.
-
GSK brushes off China probe to post solid 2013 profits
Net profits of GlaxoSmithKline, the British drug maker hit by a bribery probe in China, jumped by a fifth last year as lower taxes offset flat sales.
-
Glaxo says it will stop paying doctors to promote drugs
The announcement appears to be a first for a major drug company - although others may be considering similar moves - and it comes at a particularly sensitive time for Glaxo. It is the subject of a bribery investigation in China, where authorities contend the company funneled illegal payments to doctors and government officials in an effort to lift ...
-
China bars GlaxoSmithKline executive from leaving country amid bribery probe
Chinese authorities have barred the British finance director of GlaxoSmithKline (GSK) in China from leaving the country, the company said as it faces a bribery probe.
-
Drugmaker GSK Investigating Corruption Allegations in UAE
Britain's biggest pharmaceuticals group confirmed the investigation following allegations of improper payments set out in a whistleblower's email sent to its top management on Monday. The email, purporting to be from a GSK sales manager in the Gulf state, was seen by Reuters.
-
China to Try Foreign Investigators Linked to GSK
British national Peter Humphrey and his wife Yu Yingzeng, an American citizen, will on August 7 face charges of illegally obtaining personal information, a family friend who asked not to be identified told AFP.
-
Sex Video is New Twist in GSK China Bribery Scandal
GSK, which described the bribery allegations as "shameful" when they came to light last year, said on Sunday that it was continuing to cooperate fully with Chinese authorities on the ongoing investigation.
-
UK Fraud Office Probes GSK After Claims of Foreign Bribery
The Serious Fraud Office (SFO) said on Tuesday that its director had "opened a criminal investigation into the commercial practices of GlaxoSmithKline and its subsidiaries", confirming an earlier brief statement from the company.
-
Chinese Police Charge Former GSK China Head With Bribery
Mark Reilly, former head of China operations, and two other executives, Zhang Guowei and Zhao Hongyan, were also suspected of bribing officials in the industry and commerce departments of Beijing and Shanghai, Xinhua said.
-
GSK faces bribery investigation in Poland: report
The BBC reported that 11 doctors and a GSK regional manager have been charged over alleged corruption between 2010 and 2012.
-
GlaxoSmithKline sacks some China staff for malpractice: report
GlaxoSmithKline, facing allegations of bribery in China, has dismissed some employees in the country over failure to comply with expenses rules, a person familiar with the situation said on Friday.
-
GSK brushes off China probe to post solid 2013 profits
Net profits of GlaxoSmithKline, the British drug maker hit by a bribery probe in China, jumped by a fifth last year as lower taxes offset flat sales.
-
Glaxo says it will stop paying doctors to promote drugs
The announcement appears to be a first for a major drug company - although others may be considering similar moves - and it comes at a particularly sensitive time for Glaxo. It is the subject of a bribery investigation in China, where authorities contend the company funneled illegal payments to doctors and government officials in an effort to lift ...
-
China bars GlaxoSmithKline executive from leaving country amid bribery probe
Chinese authorities have barred the British finance director of GlaxoSmithKline (GSK) in China from leaving the country, the company said as it faces a bribery probe.
